|
|
總筆數:9
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Uniform treatment thresholds for hyperbilirubinemia in preterm infants:Background and synopsis of a national guideline |
on behalf of the BARTrial studygroup of the Netherlands Neonatal;Research Network;van Imhoff, D.E.;Dijk, P.H.;Hulzebos, C.V.; |
Early Human Development |
2011-08-01 |
查看 |
| Hyperbilirubinemia in infants with Gram-negative sepsis does not affectmortality |
van den Broek, P.;Verkade, H.J.;Hulzebos, C.V.; |
Early Human Development |
2011-08-01 |
查看 |
| Neonatal side effects of maternal labetalol treatment in severepreeclampsia |
Heida, K.Y.;Zeeman, G.G.;Van Veen, T.R.;Hulzebos, C.V.; |
Early Human Development |
2012-07-01 |
查看 |
| Neonatal side effects of maternal labetalol treatment in severepreeclampsia |
Heida, K.Y.;Zeeman, G.G.;Van Veen, T.R.;Hulzebos, C.V.; |
Early Human Development |
2012-07-01 |
查看 |
| Reply to the letter to the Editor ''Does hyperbilirubinemia in infantswith Gram-negative sepsis really not affect mortality?'' |
Hulzebos, C.V.; |
Early Human Development |
2013-10-01 |
查看 |
| Reply to the letter to the Editor ''Does hyperbilirubinemia in infantswith Gram-negative sepsis really not affect mortality?'' |
Hulzebos, C.V.; |
Early Human Development |
2013-10-01 |
查看 |
| Reply to the letter to the Editor ''Does hyperbilirubinemia in infantswith Gram-negative sepsis really not affect mortality?'' |
Hulzebos, C.V.; |
Early Human Development |
2013-10-01 |
查看 |
| Reply to the letter to the Editor ''Does hyperbilirubinemia in infantswith Gram-negative sepsis really not affect mortality?'' |
Hulzebos, C.V.; |
Early Human Development |
2013-10-01 |
查看 |
| Abdominal near-infrared spectroscopy in preterm infants: A comparisonof splanchnic oxygen saturation measurements at two abdominal locations |
Schat, T.E.;van der Laan, M.E.;Schurink, M.;Hulscher, J.B.F.;Hulzebos, C.V.;Bos, A.F.;Kooi, E.M.W.; |
Early Human Development |
2014-07-01 |
查看 |
|
|
|
